Pmda - Pharmaceuticals and Medical Devices Agency

Regulatory Science/The Science Board/Standard Development

The 1st Subcommittee on Genome Editing

Press Release

Date and Time: November 8, 2018 from 1pm to 3pm

Agenda / List of Handouts

  1. Introduction of the Subcommittee Members
  2. About the Science Board
  3. Purpose of Establishment and Future Plan on Subcommittee
    • Points to Consider for Risk Assessment of the Genome Editing Products (Dr. Teruhide Yamaguchi, Chairperson on Subcommittee)
  4. Member's lecture
    • Latest Summary of Genome Editing Technology (Dr. Tomoji Mashimo, a Member)
    • Safety of Genome Editing Technology (Dr. Kohnosuke Mitani, a Member)
  5. Others
List of Handouts
  • Document 1 List of the Subcommittee Members
  • Document 2 About the Science Board
  • Document 3 Lecture Materials (Dr. Teruhide Yamaguchi, Chairperson on Subcommittee)
  • Document 4 Lecture Materials (Dr. Tomoji Mashimo, a Member)
  • Document 5 Lecture Materials (Dr. Kohnosuke Mitani, a Member)
  • Ref.1 Provision of the Establishment of PMDA Science Board
  • Ref.2 Provision of the PMDA Science Board Subcommittees
  • Ref.3 Rules of Commission of the Member of the Science Board and the Subcommittees (to Avoid Conflict of Interests)
  • Ref.4 Standards of Handling Meeting Minutes and Other Materials
  • Ref.5 Points to Be Checked to Invite External Experts
  • Ref.6 Points to Be Confirmed on Operation of the Working Group
  • Ref.7 Cases of Past Reports, English Translations and Publications